Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 6, 2007, Pages 781-790

  Kim, J W ^a   Biederman, J ^a   Arbeitman, L ^a   Fagerness, J ^a   Doyle, A E ^a   Petty, C ^a   Perlis, R H ^a   Purcell, S ^a   Smoller, J W ^a   Faraone, S V ^b   Sklar, P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

ADHD; Association; Co morbid major depressive disorder; SNAP 25

Indexed keywords

SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ARTICLE; ATTENTION DEFICIT DISORDER; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BASE SEQUENCE; CHILD; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DNA; FEMALE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; VARIATION (GENETICS);

EID: 34548680953     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30522     Document Type: Article

References (52)

1. Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M, Schachar R, Tannock R, Kennedy JL. 2000. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry 5(4):405-409.
2. Barrett JC, Fry B, Mailer J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265.
3. Biederman J, Faraone S, Mick E, Lelon E. 1995. Psychiatric co-morbidity among referred juveniles with major depression: Fact or artifact? J Am Acad Child Adolesc Psychiatry 34(5):579-590.
4. Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, Mennin D, Marrs A, Ouellette C, Moore P, et al. 1996. Aprospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 53(5):437-446.
5. Biederman J, Faraone SV. 2005. Attention-deficit hyperactivity disorder. Lancet 366(9481):237-248.
6. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek MS, Steingard R, et al. 1992a. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of co-morbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 49(9):728-738.
7. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek MS, Steingard R, et al. 1992b. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of co-morbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 49(9):728-738.
8. Biederman J, Faraone SV, Keenan K, Knee D, Tsuang MT. 1990. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 29(4):526-533.
9. Biederman J, Faraone SV, Keenan K, Tsuang MT. 1991. Evidence of familial association between attention deficit disorder and major affective disorders. Arch Gen Psychiatry 48(7):633-642.
10. Biederman J, Faraone SV, Mick E, Williamson S, Wilens TE, Spencer TJ, Weber W, Jetton J, Kraus I, Pert J, et al. 1999. Clinical correlates of ADHD in females: Findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry 38(8):966-975.
11. Boschert U, O'Shaughnessy C, Dickinson R, Tessari M, Bendotti C, Catsicas S, Pich EM. 1996. Developmental and plasticity-related differential expression of two SNAP-25 isoforms in the rat brain. J Comp Neurol 367(2):177-193.
12. Bowden C, Cheetham SC, Lowther S, Katona CL, Crompton MR, Horton RW. 1997. Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res 769(1):135-140.
13. Brophy K, Hawi Z, Kirley A, Fitzgerald M, Gill M. 2002. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): Evidence of linkage and association in the Irish population. Mol Psychiatry 7(8):913-917.
14. Cantwell DP. 1996. Attention deficit disorder: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 35(8):978-987.
15. Castellanos FX, Elia J, Kruesi MJ, Gulotta CS, Mefford IN, Potter WZ, Ritchie GF, Rapoport JL. 1994. Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Res 52(3):305-316.
16. Chen YA, Scheller RH. 2001. SNARE-mediated membrane fusion. Nat Rev Mol Cell Biol 2(2):98-106.
17. D'Aquila PS, Collu M, Gessa GL, Serra G. 2000. The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 405(1-3):365-373.
18. Daviss WB, Bentivoglio P, Racusin R, Brown KM, Bostic JQ, Wiley L. 2001. Bupropion sustained release in adolescents with co-morbid attention-deficit/ hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry 40(3):307-314.
19. Faraone S, Biederman J, Garcia-Jetton J, Tsuang MT. 1997a. Attention deficit disorder and conduct disorder: Longitudinal evidence for a familial subtype. Psychol Med 27:291-300.
20. Faraone S, Sergeant J, Gillberg C, Biederman J. 2003a. The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2:104-113.
21. Faraone SV. 2004. Genetics of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 27(2):303-321.
22. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention deficit hyperactivity disorder. Biol Psychiatry 57(11): 1313-1323.
23. Faraone SV, Biederman J. 1997. Do attention deficit hyperactivity disorder and major depression share familial risk factors? J Nerv Ment Dis 185(9):533-541.
24. Faraone SV, Biederman J, Mennin D, Wozniak J, Spencer T. 1997b. Attention-deficit hyperactivity disorder with bipolar disorder: A familial subtype? J Am Acad Child Adolesc Psychiatry 36(10):1378-1387; discussion 1387-1390.
25. Faraone SV, Biederman J, Monuteaux MC. 2000. Attention-deficit disorder and conduct disorder in girls: Evidence for a familial subtype. Biol Psychiatry 48(1):21-29.
26. Faraone SV, Biederman J, Monuteaux MC. 2001. Attention deficit hyperactivity disorder with bipolar disorder in girls: Further evidence for a familial subtype? J Affect Disord 64(1):19-26.
27. Faraone SV, Doyle AE. 2001. The nature and heritability of attention-deficit/ hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 10(2):299-316; viii-ix.
28. Faraone SV, Glatt SJ, Tsuang MT. 2003b. The genetics of pediatric-onset bipolar disorder. Biol Psychiatry 53(11):970-977.
29. Feng Y, Crosbie J, Wigg K, Pathare T, Ickowicz A, Schachar R, Tannock R, Roberts W, Malone M, Swanson J, et al. 2005. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatry 10(11): 998-1005.
30. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al. 2002. The structure of haplotype blocks in the human genome. Science 296(5576):2225-2229.
31. Gaub M, Carlson CL. 1997. Gender differences in ADHD: A meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 36(8):1036-1045.
32. Grehan S, Allan C, Tse E, Walker D, Taylor JM. 2001. Expression of the apolipoprotein E gene in the skin is controlled by a unique downstream enhancer. J Invest Dermatol 116(1):77-84.
33. Hess EJ, Collins KA, Wilson MC. 1996. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J Neurosci 16(9):3104-3111.
34. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. 2004. Family-based tests for associating haplotypes with general phenotype data: Application to asthma genetics. Genet Epidemiol 26(1):61-69.
35. Kustanovich V, Merriman B, McGough J, McCracken JT, Smalley SL, Nelson SF. 2003. Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Mol Psychiatry 8(3):309-315.
36. Laird NM, Horvath S, Xu X. 2000. Implementing a unified approach to family-based tests of association. Genet Epidemiol 19(Suppl 1):S36-S42.
37. Lambert G, Johansson M, Agren H, Friberg P. 2000. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: Evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry 57(8):787-793.
38. Levy F, Hay DA, McStephen M, Wood C, Waldman I. 1997. Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 36(6):737-744.
39. Mick E, Biederman J, Santangelo S, Wypij D. 2003. The influence of gender in the familial association between ADHD and major depression. J Nerv Ment Dis 191(11):699-705.
40. Mill J, Richards S, Knight J, Curran S, Taylor E, Asherson P. 2004. Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatry 9(8):801-810.
41. Orvaschel H, Puig-Antich J. 1987. Schedule for affective disorders and schizophrenia for school-age children: Epidemiologic version. Fort Lauderdale, FL: Nova University.
42. Raber J, Mehta PP, Kreifeldt M, Parsons LH, Weiss F, Bloom FE, Wilson MC. 1997. Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission. J Neurochem 68(1):176-186.
43. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, et al. 2002. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 7(6):579-593.
44. Smalley SL. 1997. Genetic influences in childhood-onset psychiatric disorders: Autism and attention-deficit/hyperactivity disorder. Am J Hum Genet 60(6):1276-1282.
45. Smoller J, Biederman J, Arbeitman L, Doyle A, Fagerness J, Perlis R, Sklar P, Faraone S. 2006. Association between the 5HTR1B Receptor Gene (HTR1B) and the Inattentive Subtype of ADHD. Biol Psychiatry 59(5):460-467.
46. Smoller JW, Lunetta KL, Robins J. 2000. Implications of co-morbidity and ascertainment bias for identifying disease genes. Am J Med Genet 96(6):817-822.
47. Steffensen SC, Henriksen SJ, Wilson MC. 1999. Transgenic rescue of SNAP-25 restores dopamine-modulated synaptic transmission in the coloboma mutant. Brain Res 847(2):186-195.
48. Thapar A, Harrington R, Ross K, McGuffin P. 2000. Does the definition of ADHD affect heritability? J Am Acad Child Adolesc Psychiatry 39(12):1528-1536.
49. Thapar A, Hervas A, McGuffin P. 1995. Childhood hyperactivity scores are highly heritable and show sibling competition effects: Twin study evidence. Behav Genet 25(6):537-544.
50. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, Franceschi D. 2001. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21(2):RC121.
51. Washbourne P, Thompson PM, Carta M, Costa ET, Mathews JR, Lopez-Bendito G, Molnar Z, Becher MW, Valenzuela CF, Partridge LD, et al. 2002. Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat Neurosci 5(1):19-26.
52. Wilson MC. 2000. Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder. Neurosci Biobehav Rev 24(1):51-57.